• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

Exactech Declares Bankruptcy Amid Mounting Legal Challenges Over Defective Implants

November 2, 2024 By SPINEMarketGroup

Exactech, a medical device company headquartered in Gainesville, Florida, has filed for bankruptcy protection amid ongoing legal battles. The company faces more than 2,000 lawsuits in both state and federal courts from patients who claim they received defective hip and knee implants. To address its financial strain, Exactech announced a plan to restructure its operations and sell its assets to a private investor group comprising private equity and alternative asset firms. This move would provide approximately $85 million in new financing to keep the company operational during the restructuring process.

Darin Johnson, Exactech’s president and CEO, explained that the financial liabilities stemming from lawsuits over its hip and knee products became unsustainable. He noted that these lawsuits largely relate to voluntary recalls initiated between 2021 and 2022 due to packaging issues. Despite the bankruptcy proceedings, the company intends to continue operating.

The bankruptcy filing, processed in a Delaware federal court, will halt ongoing litigation, including the cases scheduled to go to trial soon. This unexpected development has disappointed attorneys representing injured patients who anticipated that one of the first jury trials against Exactech would begin in December in Alachua County, Florida. Lawyer Andrew Saunders criticized the bankruptcy move, claiming it obstructs the public trial and obscures accountability for the company’s alleged misconduct.

Over the past 30 years, Exactech has evolved from a small-scale medical device manufacturer to a global corporation. However, recent investigative findings by KFF Health News, published in October 2023, highlighted the company’s delays in reporting adverse events to federal regulators, as required by law. This investigation revealed that Exactech had failed to report hundreds of issues in a timely manner to a national database monitoring medical device performance and safety.

A significant number of lawsuits claim that Exactech’s knee and hip implants suffered from high failure and complication rates, often requiring patients to undergo revision surgeries much earlier than expected. Exactech, while refuting these allegations, has issued multiple recalls since August 2021, affecting its artificial knee, hip, and ankle products. The initial recall cited packaging problems dating back as far as 2004, which allegedly caused premature degradation of a plastic component in approximately 140,000 implants. A review of 300 ongoing cases in Alachua County showed that, in many instances, the implants failed within seven years—well short of the typical 15-20 year lifespan expected for these devices.

The outcome of Exactech’s restructuring and its impact on the pending cases will be closely watched by affected patients and the medical device industry.

Related Posts:

  • Johnson & Johnson Explores Potential $20B Sale of…
  • Dynabolt
  • J&J Hit with $442M Antitrust Verdict Amid Growing…

Filed Under: NEWS Tagged With: 2024

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • Globus Medical and Synaptive: Why the Rumors Deserve…
  • What Globus Medical Really Bought With Higgs Boson Health
  • BROCHURES
  • Globus Medical Announces Acquisition of Higgs Boson…
  • Neck and Neck: Is Globus Finally About to Overtake…
  • Who Runs DePuy Synthes? The CEO Fight That Killed…
  • Globus Medical to Showcase SCRIPT™ Patient-Specific…
  • J&J’s $21B DePuy Synthes Bet Could End in…
  • Federal Circuit Backs Globus Medical in Spinal…
  • Centinel Spine Files for NYSE IPO After 42% Jump in…
  • COMPANIES
  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • Do Spine Companies Really Need So Many Implants?…
  • Record Earnings, Discount Valuation: What Globus…
  • New CFO, New AI Chief and a Patent Fight: What Is…
  • Globus Medical Reports Third Quarter 2026 Results…
  • CD HORIZON® SOLERA™ System
  • (UPDATED 2026) More Than 100 Options, No Single…
  • 3D-Printed Cages Are Everywhere. Has the Technology…
  • Top Expandable Cages of 2025: Which Lumbar Implants…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • Globus Medical Acquires Synaptive Medical,…
  • Forty Cervical Discs, One 3% Market: The Fight to…
  • SYMPHONY Occipito-Cervico-Thoracic (OCT) System
  • What Is a Spine Hub, and Why Did Avesi Invest in New…
  • Whatever Happened to the Translational Cervical…
  • Posterior Cervical: The Segment Everyone Serves and…
  • Thinking About a Spine Robot? Your 2026 Guide to the…
  • Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
  • Is DePuy Back in the Spine Fight? Why DePuy Really…
  • LAST 5 VIDEOS PUBLISHED

    1. GS Medical: QUASAR™ Stand-Alone ACIF
    2. SI-BONE: iFuse Granite Onyx™
    3. NovaSpine: DIVA Cervical
    4. Xenix Medical: Riva Modular Fixation System
    5. Spinal Elements: Overwatch® PCF

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup